ArticleCancer medicine2020

Improved outcomes after radiotherapy for prostate cancer: Anticoagulation, antiplatelet therapy, and platelet count as key factors in disease progression.

Stanley I Gutiontov et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.